These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [99m Tc-sestamibi in the diagnosis of the location of hyperparathyroidism]. Berná Roqueta L Rev Esp Med Nucl; 1998; 17(2):102-11. PubMed ID: 9611280 [No Abstract] [Full Text] [Related]
3. Value of sestamibi scans in tertiary hyperparathyroidism. Loftus KA; Anderson S; Mulloy AL; Terris DJ Laryngoscope; 2007 Dec; 117(12):2135-8. PubMed ID: 17891049 [TBL] [Abstract][Full Text] [Related]
4. Multimodality imaging of the parathyroid glands in primary hyperparathyroidism. Shah S; Win Z; Al-Nahhas A Minerva Endocrinol; 2008 Sep; 33(3):193-202. PubMed ID: 18846025 [TBL] [Abstract][Full Text] [Related]
5. Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy. Schachter PP; Issa N; Shimonov M; Czerniak A; Lorberboym M Arch Surg; 2004 Apr; 139(4):433-7. PubMed ID: 15078713 [TBL] [Abstract][Full Text] [Related]
6. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Casara D; Rubello D; Pelizzo MR; Shapiro B Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294 [TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism. Billy HT; Rimkus DR; Hartzman S; Latimer RG Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462 [TBL] [Abstract][Full Text] [Related]
8. Preliminary experience with double-phase SPECT using Tc-99m sestamibi in patients with hyperparathyroidism. Neumann DR; Esselstyn CB; Kim EY; Go RT; Obuchowski NA; Rice TW Clin Nucl Med; 1997 Apr; 22(4):217-21. PubMed ID: 9099475 [TBL] [Abstract][Full Text] [Related]